Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
18 Jul 2018 ESMO Releases New Patient Guide in Breast Cancer Breast cancer
18 Jul 2018 FDA Broadens Approval for Enzalutamide to Include Non-Metastatic Castration-Resistant Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
17 Jul 2018 NICE Issues Guideline for Primary Brain Tumours and Brain Metastases in Adults Central nervous system malignancies
16 Jul 2018 A Comprehensive Catalogue of Stromal Cells in Human Lung Tumours at Single-Cell Resolution Lung and other thoracic tumours - Translational research
13 Jul 2018 FDA Grants Accelerated Approval to Ipilimumab in Combination with Nivolumab for MSI-H or dMMR mCRC Gastrointestinal cancers - Cancer Immunology and Immunotherapy
12 Jul 2018 EMA Recommends Granting a Marketing Authorisation for Liposomal Formulation of a Fixed Combination of Daunorubicin and Cytarabine Haematologic malignancies - Anticancer agents & Biologic therapy
11 Jul 2018 FDA Approves the Ventana PD-L1 (SP142) Assay for PD L1 Expression in ≥ 5% IC in Urothelial Carcinoma Tissue Genitourinary cancers - Personalised medicine - Cancer Immunology and Immunotherapy
10 Jul 2018 Study Identifies Factors Associated with Diffuse Intrinsic Pontine Glioma that Indicate Better Survival Central nervous system malignancies
09 Jul 2018 EMA Recommends Granting Marketing Authorisations for the First Two CAR T-cell Therapies in the EU Haematologic malignancies - Cancer Immunology and Immunotherapy
06 Jul 2018 Immune Driver of Castration-Resistant Prostate Cancer Identified Genitourinary cancers - Basic science - Translational research
05 Jul 2018 Comparison of Available Treatment Strategies and Chemotherapeutic Options for Locally Advanced Head and Neck Cancer Head and neck cancers - Anticancer agents & Biologic therapy
04 Jul 2018 EMA Recommends Extension of Indications for Lenvatinib Gastrointestinal cancers - Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
02 Jul 2018 EMA Recommends Extension of Indications for Nivolumab Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
02 Jul 2018 EMA Recommends Granting a Marketing Authorisation for Neratinib After Re-examining Its Negative Opinion for This Medicine Breast cancer - Anticancer agents & Biologic therapy
28 Jun 2018 Survivors of Childhood Extracranial Malignancy Who Received Chemotherapy Are Likely to Have Long-Term Neurological Toxicity Cancer in Special Situations